The manufacturer of Ozempic is testing amycretin, an experimental weight-loss pill that appears to help people quickly shed pounds.

Eli Lilly, the makers of tirzepatide—which they sell as Mounjaro for diabetes and Zepbound for weight loss— announced recently that in its longest study yet on tirzepatide, the drug reduced the risk of people with prediabetes moving on to develop diabetes by 94% compared to those taking a placebo.

As a health journalist, I’m doing my best to keep up with all things weight loss drugs, but with headlines rolling in every day, it’s not easy! If you’re trying to stay on top of the latest, consider this your quick reference guide.